Complications of cytostatic therapy in childhood leukemia.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D001344:Autopsy; D001932:Brain Neoplasms; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms; D007938:Leukemia / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008113:Liver Neoplasms; D008175:Lung Neoplasms; D008207:Lymphatic Metastasis; D008297:Male; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D003561:Cytarabine; D001215:Asparaginase